The two products are said to be bioequivalent if they are only pharmaceutically equivalent and their rate and extent of availability after administration in the same molar dose are similar and it can also be defined as absence of a greater-than-allowable difference between the systemic bioavailability of a test product and that of a reference product.
Related Journals
Journal of Therapeutic Advances in Drug Safety; Journal of Investigational New Drugs; Journal of Pharmaceutical Research; Journal of Drugs ; Drug Metabolism Reviews; Journal of Pharmacology and Therapeutics.
Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report